NCT06633263

Brief Summary

The goals of this interventional study is to study if the combine effects of Behavioral Activation Treatment for Depression (BATD) and Cognitive Behavioral Therapy for Insomnia (CBT-I) is effective on primary outcomes : depression, insomnia, well-being and anxiety and secondary outcomes : worry, rumination, behavioral inertia, experiential avoidance, anticipatory pleasure deficits, cognitive resource deficits, emotional reactivity, quality of sleep, and sleep beliefs for participants suffering from depression and insomnia disorders.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Oct 2024Jun 2027

First Submitted

Initial submission to the registry

October 2, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 9, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

October 21, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

November 1, 2024

Status Verified

October 1, 2024

Enrollment Period

2.7 years

First QC Date

October 2, 2024

Last Update Submit

October 29, 2024

Conditions

Keywords

depressioninsomniaCBT-IBATDcombined interventionmultiple case studySingle Case Experimental Design

Outcome Measures

Primary Outcomes (6)

  • Anxiety

    Generalised Anxiety Disorder Questionnaire. Scores ranges from 0 to 21. Higher scores means worse outcome (higher anxiety symptoms)

    Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  • Depression

    Patient Health Questionnaire. Scores ranges from 0 to 27. Higher scores means worse outcome (higher depressive symptoms)

    Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  • Insomnia

    Insomnia Severity Index. Scores ranges from 0 to 28. Higher scores means worse outcome (higher insomnia)

    Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  • Fatigue

    Multidimensional Fatigue Inventory - General and physical fatigue. Scores ranges from 9 to 45. Higher scores means worse outcome (higher general and physical fatigue).

    Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  • Well-being

    Well-being - Warwick-Edinburgh Mental Wellbeing Scale. Scores ranges from 14 to 70. Higher scores means better outcome (higher well-being)

    Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  • Socio-démographic Questionnaires

    Age, gender, socio-economical status, situation at home

    Up to two weeks before the intervention

Secondary Outcomes (12)

  • Sleep Beliefs

    Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  • Client satisfaction

    Two measures. up to two weeks after the first intervention, up to two weeks after the second intervention,

  • Activation

    Everyday through intervention completion (from week 1 up to 16 weeks later)

  • Rumination

    Everyday through intervention completion (from week 1 up to 16 weeks later)

  • Anticipatory pleasure

    Everyday through intervention completion (from week 1 up to 16 weeks later)

  • +7 more secondary outcomes

Other Outcomes (1)

  • Qualitative Interview

    Three measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention

Study Arms (2)

CBT-I followed by BATD

EXPERIMENTAL

1. Five group CBT-I sessions of two hours, one per week. 2. Two-week break - baseline 3. Five individual BATD sessions of one hour, one per week. Because of the diverse content of ruminations and avoidances in depression (Blairy et al., 2020), AC therapy will be administered in an individual format, while CBT-I will take place in a group setting.

Behavioral: Cognitive Behavioral Therapy for InsomniaBehavioral: Behavioral Activation Treatment for Depression

BATD followed by CBT-I

EXPERIMENTAL

1. Five individual BATD sessions of one hour, one per week. Because of the diverse content of ruminations and avoidances in depression (Blairy et al., 2020), AC therapy will be administered in an individual format, while CBT-I will take place in a group setting. 2. Two-week break - baseline 3. Five group CBT-I sessions of two hours, one per week.

Behavioral: Cognitive Behavioral Therapy for InsomniaBehavioral: Behavioral Activation Treatment for Depression

Interventions

Introduce self-recording with the sleep diary; Introduce basic notions of insomnia; Introduce basic notions of sleep hygiene; Introduce basic notions of sleep; Recreate a time and place dedicated to sleep; Limit time spent in bed to time slept; Promote attitudes and beliefs that favor sleep and manage worries; Relapse prevention. This intervention is empirically validated (Morin, 2022).

BATD followed by CBT-ICBT-I followed by BATD

Introduce self-recording with daily activities; Introduce the basic concept of depression; Identify and increase activities associated with positive reinforcement; Reflect on life domains and values to identify reinforcing activities; Identify and decrease activities associated with negative reinforcement; Identify and decrease activities associated with negative reinforcement; Relapse prevention. This intervention is empirically validated (Ciharova et al., 2021)

BATD followed by CBT-ICBT-I followed by BATD

Eligibility Criteria

Age18 Years - 67 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be adults with depression (PhQ 9 \> 10; cut-off for moderate depression) and insomnia (Insomnia Severity Index \> 11) who also meet DSM-V criteria for depression and insomnia (APA, 2013) and have a good understanding of French.

You may not qualify if:

  • Participants requiring different treatment, i.e. those with symptoms suggestive of psychotic disorder, bipolar disorder, substance abuse disorder, excessive suicidal ideation, or other sleep pathology (such as sleep apnea, restless legs syndrome, narcolepsy, sleepwalking, or periodic limb movements)
  • Participants who have recently received or are currently receiving other interventions that could be confused with our intervention, such as those undergoing treatment for sleep or depression, or those undergoing parallel psychological or pharmacological treatment (antidepressants and anxiolytics will be accepted provided they have been stabilized for at least two months and there are no planned changes in the following weeks).
  • Participants with commitments that disrupt nocturnal sleep cycles and habits, such as those who no longer work or who work night shifts, will also be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CPLU (clinique psychologique et logopédique de l université de Liège)

Liège, 4000, Belgium

Location

Related Links

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersDepression

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: In condition 1 : CBT-I precede BATD In condition 2 : BATD precede CBT-I Condition 1 is starting in Novembre Condition 2 is starting in February
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 2, 2024

First Posted

October 9, 2024

Study Start

October 21, 2024

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

November 1, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

all IPD collected throughout the trial

Shared Documents
CSR
Time Frame
Beginning after publication with no end date
Access Criteria
meta-analysis and that must be approved by the investigator

Available IPD Datasets

Study Protocol Access
Individual Participant Data Set Access

Locations